| Net income | |
| Depreciation | |
| Amortization | |
| Bad debt expense | |
| Deferred income tax benefit | -5.89M |
| Share-based compensation | 2.61M |
| Other noncash charges | |
| Accounts receivable | -3.57M |
| Other assets | -1.04M |
| Income taxes | -476K |
| Accounts payable and accrued expenses | 5.63M |
| Other liabilities | 482K |
| Net cash provided by operating activities | |
| Other acquisition related payments | |
| Purchases of property and equipment | -5.02M |
| Other investing activities | |
| Net cash used in investing activities | |
| Repayment of debt | -60K |
| Borrowings under our revolving credit facility | 57.2M |
| Debt issuance costs | -1.18M |
| Repurchase of stock for restricted stock tax withholdings | -603K |
| Net cash used in financing activities | |
| Effect of exchange rate changes on cash | |
| Change in cash and cash equivalents | 24.25M |
| Cash and cash equivalents at beginning of period | 2.45M |
| Cash and cash equivalents at end of period | 26.71M |